Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
06/10/1998 | EP0846126A1 Tricyclic antidepressant derivatives and conjugated useful in immunoassays |
06/10/1998 | EP0845998A1 Immunotherapy medicaments containing antibodies which specifically detect the mhcii antigen of a patient to be treated |
06/10/1998 | EP0845995A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
06/10/1998 | EP0733106A4 Plant arabinogalactan protein (agp) genes |
06/10/1998 | EP0721346B1 Methods for inducing antigen-specific t cell tolerance |
06/10/1998 | EP0686263A4 Competitive immunoassay utilizing binding protein in a multiclonal antibody format |
06/10/1998 | EP0487627B1 Wound healing preparations containing heparanase |
06/10/1998 | CN1184531A Method for diagnosing a patient for chlamydia |
06/10/1998 | CN1184484A Novel anti-AIDS immunotoxins |
06/10/1998 | CN1038693C Process for fermentative preparation of amino acids |
06/09/1998 | US5763733 Antigen-binding fusion proteins |
06/09/1998 | US5763580 A polypeptide analogs of hgpiib c-terminal fragment, useful for diagnosis of blood clotting and thrombi |
06/09/1998 | US5763578 All-trans retinaldehyde binding protein, and antibodies thereto |
06/09/1998 | US5763574 HIV-specific synthetic antigens and their use |
06/09/1998 | US5763573 GTPase activating protein fragments |
06/09/1998 | US5763572 HTLV-II peptide antigens |
06/09/1998 | US5763570 Glutathione analogs and paralog panels comprising glutathione mimics |
06/09/1998 | US5763441 Administering to the patient suffering from diabetes, glioma, hemangioma, kaposi's sarcoma, ovarian/breast/pancreatic/colon and prostate cancer a benzo(g)quinoxaline compounds |
06/09/1998 | US5763411 Solid support coated with fibrin monomer readily capable of being converted to fibrin polymer sealant or hemostat |
06/09/1998 | US5763410 Kit for preparing a fibrin sealant |
06/09/1998 | US5763274 Antibody 103B2 |
06/09/1998 | US5763272 Amino acid sequence of cells for monoclonal antibodies |
06/09/1998 | US5763249 Antibody-mediated reduction of α-ketoamides |
06/09/1998 | US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus |
06/09/1998 | US5763224 Genetic engineered complementary dna |
06/09/1998 | US5763223 DNA encoding a cytokine that induces apoptosis |
06/09/1998 | US5763220 Human apoptosis-related calcium-binding protein |
06/09/1998 | US5763219 Cyclin E variants and use thereof |
06/09/1998 | US5763214 Fibroblast growth factor 11 |
06/09/1998 | US5763213 Sensory and motor neuron derived factor (SMDF) |
06/09/1998 | US5763211 Polynucleotide which encodes receptor polypeptide |
06/09/1998 | US5763210 Recombinant production of interferon-gamma binding proteins |
06/09/1998 | US5763209 Methods and materials relating to the functional domains of DNA binding proteins |
06/09/1998 | US5763202 Medical diagnosis of prostate cancer; enzyme-linked immunosorbent assay |
06/09/1998 | US5763195 Method and compositions for making ACSF and ACSF antagonists |
06/09/1998 | US5763159 Hepatitis-C virus testing |
06/09/1998 | US5763156 Effective in regulating inflammatory platelet and endothelial sitmulatory and coagulopathic responses by modulating the activity of the c5b-9 complex of the human plasma complement system by adding a fluorescent potentiometric dye |
06/09/1998 | US5762934 Clostridium difficile toxin disease therapy |
06/09/1998 | US5762933 Administering |
06/09/1998 | US5762931 Anti-cancer utility of HCG vaccines |
06/09/1998 | US5762930 Bispecific reagents for redirected targeting of human lipoproteins |
06/09/1998 | US5762927 Exposing primate to immunotoxin, administering lymph node lymphocytes, transplanting organ |
06/09/1998 | US5762921 Composition and methods for the treatment of tumors |
06/09/1998 | US5762906 Further improvements relating to radiolabelling of proteins |
06/09/1998 | US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
06/09/1998 | US5762805 Transferring matter to or from blood, semipermeable membranes, filters and controlling flow |
06/04/1998 | WO1998023963A1 Methods and reagents for determining protein s |
06/04/1998 | WO1998023775A2 Dna for evaluating the progression potential of cervical lesions |
06/04/1998 | WO1998023761A1 HUMANIZED ANTI-CD11a ANTIBODIES |
06/04/1998 | WO1998023760A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
06/04/1998 | WO1998023759A2 Identification of inhibitors that prevent access of telomerase to chromosomal terminus |
06/04/1998 | WO1998023755A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
06/04/1998 | WO1998023752A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses |
06/04/1998 | WO1998023750A2 Mammalian chemokines |
06/04/1998 | WO1998023749A1 Fibroblast growth factor-13 |
06/04/1998 | WO1998023746A1 Antibody mutants |
06/04/1998 | WO1998023745A1 Human sqm1 protein homolog comprising a cell adhesion protein |
06/04/1998 | WO1998023743A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof |
06/04/1998 | WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses |
06/04/1998 | WO1998023737A1 Production of in vivo labeled single chain synthetic antibody fragments |
06/04/1998 | WO1998023646A2 Binding agents specific for iga receptor |
06/04/1998 | WO1998023645A1 Affinity purification of polypeptide on protein a matrix |
06/04/1998 | WO1998023641A1 Dna encoding lepidopteran-active delta-endotoxins and its use |
06/04/1998 | WO1998023631A1 Novel bacterial polypeptides and polynucleotides |
06/04/1998 | WO1998023289A1 MODULATION OF IgG BINDING TO FcRn |
06/04/1998 | WO1998023287A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
06/04/1998 | WO1998023286A2 Immunoconjugates comprising human monoclonal antibodies or fragments thereof for diagnostic and therapy |
06/04/1998 | WO1998013493A3 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
06/04/1998 | WO1998000171A3 Conjugates of thrombin inhibitors and endogenes carriers |
06/04/1998 | CA2274313A1 Mammalian chemokines |
06/04/1998 | CA2274143A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof |
06/04/1998 | CA2272989A1 Identification of inhibitors that prevent access of telomerase to chromosomal terminus |
06/04/1998 | CA2272847A1 Dna encoding lepidopteran-active delta-endotoxins and its use |
06/04/1998 | CA2272632A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
06/04/1998 | CA2272239A1 Fibroblast growth factor-13 |
06/04/1998 | CA2270283A1 Human sqm1 protein homolog comprising a cell adhesion protein |
06/04/1998 | CA2243944A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
06/03/1998 | EP0845540A1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same |
06/03/1998 | EP0845535A2 Leader peptidase (lep) from Streptococcus |
06/03/1998 | EP0845529A2 Human G-protein coupled receptor protein cloned form fetal brain CDNA library |
06/03/1998 | EP0845037A1 Globulin protein 11s, usable as a seed impregnation marker during germination. |
06/03/1998 | EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
06/03/1998 | EP0845035A2 Urocortin peptides |
06/03/1998 | EP0845007A2 Pharmaceutical composition containing inhibitors of interferon-gamma |
06/03/1998 | EP0845006A2 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
06/03/1998 | EP0845005A1 Traf inhibitors |
06/03/1998 | EP0845004A1 Epitope tagging system |
06/03/1998 | EP0844885A2 Chemical compounds |
06/03/1998 | EP0844874A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF $g(a) v?$g(b) 5? MEDIATED ANGIOGENESIS |
06/03/1998 | EP0833834A4 Dna sequence and encoded mammary-specific breast cancer protein |
06/03/1998 | CN1183811A Method for isolation and purification of lipid cell-wall components |
06/03/1998 | CN1183806A Polynucleotide immunogenic agents |
06/03/1998 | CN1183805A Chemokine receptos 88-2B £CKR-3| and 88C and their antibodies |
06/03/1998 | CN1183802A Method for producing immunoglobulins contg. protection proteins in plants and their use |
06/02/1998 | US5760186 Inflammatory cytokine, diagnosis and therapy |
06/02/1998 | US5760185 Anti-feline herpes virus-1 recombinant antibody and gene fragment coding for said antibody |
06/02/1998 | US5760181 Endotoxins |
06/02/1998 | US5760180 Kits and dna(cdna) codes and cloning expression vectors |
06/02/1998 | US5760178 Antitumor |
06/02/1998 | US5760166 Having available anhydride functional groups capable of immobilizing biological molecules and hydrolyzed anhydride functional groups |